565 related articles for article (PubMed ID: 7477219)
1. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
Køber L; Torp-Pedersen C; Carlsen JE; Bagger H; Eliasen P; Lyngborg K; Videbaek J; Cole DS; Auclert L; Pauly NC
N Engl J Med; 1995 Dec; 333(25):1670-6. PubMed ID: 7477219
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease.
Udell JA; Morrow DA; Jarolim P; Sloan S; Hoffman EB; O'Donnell TF; Vora AN; Omland T; Solomon SD; Pfeffer MA; Braunwald E; Sabatine MS
J Am Coll Cardiol; 2014 Jun; 63(22):2421-8. PubMed ID: 24727254
[TBL] [Abstract][Full Text] [Related]
3. Decreasing the Risk of Heart Failure in a Changing Post-Myocardial Infarction Environment.
Rouleau J
N Engl J Med; 2024 Apr; 390(16):1524-1526. PubMed ID: 38587253
[No Abstract] [Full Text] [Related]
4. Safety and costs of initiating angiotensin converting enzyme inhibitors for heart failure in primary care: analysis of individual patient data from studies of left ventricular dysfunction.
Mason J; Young P; Freemantle N; Hobbs R
BMJ; 2000 Nov; 321(7269):1113-6. PubMed ID: 11061732
[TBL] [Abstract][Full Text] [Related]
5. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.
Lancet; 1993 Oct; 342(8875):821-8. PubMed ID: 8104270
[TBL] [Abstract][Full Text] [Related]
6. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico.
Lancet; 1994 May; 343(8906):1115-22. PubMed ID: 7910229
[TBL] [Abstract][Full Text] [Related]
7. The TRAndolapril Cardiac Evaluation (TRACE) study: rationale, design, and baseline characteristics of the screened population. The Trace Study Group.
Am J Cardiol; 1994 Apr; 73(10):44C-50C. PubMed ID: 8166055
[TBL] [Abstract][Full Text] [Related]
8. The Survival and Ventricular Enlargement (SAVE) study: rationale and perspective.
Pfeffer MA
Herz; 1993 Dec; 18 Suppl 1():430-5. PubMed ID: 8125423
[TBL] [Abstract][Full Text] [Related]
9. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.
Lancet; 1995 Mar; 345(8951):669-85. PubMed ID: 7661937
[TBL] [Abstract][Full Text] [Related]
10. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).
Pitt B; Segal R; Martinez FA; Meurers G; Cowley AJ; Thomas I; Deedwania PC; Ney DE; Snavely DB; Chang PI
Lancet; 1997 Mar; 349(9054):747-52. PubMed ID: 9074572
[TBL] [Abstract][Full Text] [Related]
11. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
Packer M; Bristow MR; Cohn JN; Colucci WS; Fowler MB; Gilbert EM; Shusterman NH
N Engl J Med; 1996 May; 334(21):1349-55. PubMed ID: 8614419
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.
Circulation; 1994 Oct; 90(4):1765-73. PubMed ID: 7923660
[TBL] [Abstract][Full Text] [Related]
13. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.
Garg R; Yusuf S
JAMA; 1995 May; 273(18):1450-6. PubMed ID: 7654275
[TBL] [Abstract][Full Text] [Related]
14. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.
Ambrosioni E; Borghi C; Magnani B
N Engl J Med; 1995 Jan; 332(2):80-5. PubMed ID: 7990904
[TBL] [Abstract][Full Text] [Related]
15. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.
Cleland JG; Erhardt L; Murray G; Hall AS; Ball SG
Eur Heart J; 1997 Jan; 18(1):41-51. PubMed ID: 9049514
[TBL] [Abstract][Full Text] [Related]
16. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group.
Circulation; 1998 Jun; 97(22):2202-12. PubMed ID: 9631869
[TBL] [Abstract][Full Text] [Related]
17. Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1).
Lancet; 1995 Mar; 345(8951):686-7. PubMed ID: 7885123
[TBL] [Abstract][Full Text] [Related]
18. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Loeb HS; Johnson G; Henrick A; Smith R; Wilson J; Cremo R; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI78-87. PubMed ID: 8500244
[TBL] [Abstract][Full Text] [Related]
19. The effect of digoxin on mortality and morbidity in patients with heart failure.
Digitalis Investigation Group
N Engl J Med; 1997 Feb; 336(8):525-33. PubMed ID: 9036306
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
